In prostate cancer, overexpression of ISG15 is regulated by hypoxia-inducible factors (HIF) under hypoxic conditions promoting the release of the anti-apoptotic protein Bcl2, which inhibits apoptosis [30]. The gene discussed is ISG15; the disease is prostate carcinoma.